High Tide (HITI) announced its intention to enter into the German medical cannabis market by acquiring a 51% interest in Purecan for approximately EUR 4.8M. During ongoing due diligence, the company reassessed the optimal structure for this transaction and is now exploring alternative arrangements with Purecan to allow High Tide to maintain its planned commercial exposure into the German market. There is no certainty that an alternative arrangement with Purecan will proceed. High Tide will update the market as required. The Company continues to be committed to the German medical cannabis market and will explore both alternative structures with Purecan and other opportunities for entry into Germany.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HITI:
- High Tide Secures Spot in TSX Venture’s Top 50 Companies Again
- High Tide Expands Canna Cabana Retail Footprint and Enters German Market
- High Tide price target raised to C$5.50 from C$4.75 at Canaccord
- High Tide management to meet virtually with Roth MKM
- High Tide Inc. Celebrates Record Earnings and Growth